Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Ocul Surf. 2022 Mar 29;25:8–18. doi: 10.1016/j.jtos.2022.03.006

Table 1:

Patient characteristics with ocular surface squamous neoplasia

Case # Sex Age
(years)		 Eye LC Conjunctiva Cornea Treatment Outcome P M TR
P G L
1 M 38 OD N + - + + 5-FU, MMC Resolution + + +
2 M 56 OS N − + − + 5-FU, IFN α-2b Resolution + + +
3 F 60 OS N − + − + 5-FU Resolution + + +
4 F 46 OD T − + − − 5-FU, MMC Resolution Neg post Tx Bx + + +
5 M 70 OS T − + − + 5-FU Resolution + + +
6 M 79 OD N − + − + 5-FU Resolution + + +
7 F 69 OS T + + − + 5-FU Resolution Neg post Tx Bx + + +
8 M 66 OS N − + − − 5-FU Resolution Neg post Tx Bx + + +
9 M 46 OD T − + + + 5-FU Resolution + + +
10 M 84 OD T − + − + 5-FU Resolution + + +

LC; location, LKNV; length of corneal neo-vessel invasion, F; female, M; male, OS; left eye, OD; right eye, P; papillary, G; gelatinous, L; leukoplakic, T; temporal, N; nasal, S; superior, 5-FU; 5-fluorouracil, MMC; mitomycin, IFN α-2b; Interferon α-2b, P; presentation, M; mid-treatment, TR; tumor resolution, Neg post Tx Bx; Negative post treatment biopsy.